Establishing secure connection…Loading editor…Preparing document…

Healthcare Collaborative Exhibit

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE COLLABORATIVE EXHIBIT

This Healthcare Collaborative Exhibit ("Exhibit") sets forth the terms, responsibilities, and operational protocols for the coordination of patient care and information exchange between the parties identified below. Effective Date:

Parties

Lead Entity Type:

Patient Information

Date of Birth:   Gender:

Insurance Information

Medical History & Current Clinical Information

Scope of Collaboration

The parties agree to collaborate in the coordination of clinical care for the identified patient. The collaborative activities may include shared care planning, transfer of clinical records, joint prescribing protocols where legally permitted, and defined referral pathways. Specific scope description:

Responsibilities of Parties

Each party shall perform the responsibilities assigned in this Exhibit, including but not limited to: ensuring clinician licensure, maintaining required malpractice coverage, timely documentation of care, and adherence to agreed clinical protocols.

Data Sharing, Confidentiality, and HIPAA Compliance

The parties will exchange Protected Health Information only to the minimum extent necessary to accomplish the permitted purposes of this Exhibit. All disclosures shall comply with applicable privacy laws and the Health Insurance Portability and Accountability Act (HIPAA) requirements. Each party shall:

Breach notification: In the event of an unauthorized disclosure or breach affecting shared PHI, the disclosing party will notify the other party promptly and cooperate in mitigation and notification consistent with law.

Liability, Indemnification, and Insurance

Each party remains responsible for its own acts and omissions. To the fullest extent permitted by law, a party shall indemnify and hold harmless the other party from claims arising from the indemnifying party's negligence or willful misconduct in connection with the collaborative activities. Each party warrants it maintains malpractice insurance at levels required by applicable law and clinical privilege agreements.

Term, Termination, and Amendment

This Exhibit commences on the Effective Date and continues until the earlier of: completion of the coordinated care episode, expiration of patient authorization, or termination by either party following prior written notice. Termination without cause requires notice: days' written notice.

Amendments to this Exhibit must be made in writing and signed by authorized representatives of both parties.

Certifications and Attestations

Each party certifies that it is duly organized and authorized to enter into this Exhibit, that clinical personnel are appropriately licensed, and that it will comply with all applicable federal, state, and local laws in the performance of its obligations hereunder.


Acknowledgment

By signing below, the parties confirm the accuracy of the information provided in this Exhibit, agree to the terms and responsibilities set forth, and authorize the limited exchange of Protected Health Information as necessary to accomplish the collaborative care described herein.

Lead Entity:

By:

Date:

Collaborating Entity:

By:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What the Healthcare Collaborative Exhibit Is and When It’s Used

A Healthcare Collaborative Exhibit is an attached schedule or exhibit to a master agreement that documents the operational, legal, and technical terms for data sharing, joint quality improvement, research, or population health activities between healthcare entities. It defines parties, data elements, permitted uses, security controls, audit and retention obligations, and reporting requirements. The exhibit clarifies responsibilities for protected health information (PHI), references any required business associate agreement (BAA), and establishes the effective date, term, and termination procedures for collaborative activities.

Why a Clear Exhibit Matters for Compliance and Collaboration

A well-drafted Healthcare Collaborative Exhibit reduces ambiguity about permitted data uses, documents consent and safeguards for PHI under HIPAA, and supports enforceability under ESIGN/UETA when executed electronically. It aligns operational expectations across clinical, research, legal, and IT teams and helps demonstrate due diligence in audits or regulatory reviews.

Why a Clear Exhibit Matters for Compliance and Collaboration

Who Typically Prepares and Signs This Exhibit

Multiple stakeholders prepare or approve collaborative exhibits depending on the arrangement and the data involved.

  • Health systems and hospitals — legal, compliance, and IT coordinate terms for PHI exchange and security controls.
  • Clinical research organizations and academic partners — define data sets, de‑identification, IRB oversight, and permitted research uses.
  • Payors and government agencies — specify claims data transfer, limited data sets, and reporting obligations.

Ensure the identified business owners, privacy officers, and authorized signers review the exhibit to confirm operational feasibility and legal compliance.

Core Components Every Professional Exhibit Should Include

A concise exhibit organizes legal and technical items so operational teams can implement the collaboration without repeated legal review.

Parties & Roles

Identify each collaborating entity, their business role, responsibility matrix, and primary contact for privacy and security matters, so accountability is explicit.

Data Scope

Describe exact data elements or categories (PHI fields, limited data set, de-identified data), formats, and frequency of transfers to avoid downstream misinterpretation.

Permitted Uses

State allowed purposes (treatment, operations, research), prohibited uses, and any secondary-use restrictions, including re-disclosure limits and publication policies.

Security Controls

List encryption, access controls, authentication methods, logging, and incident response requirements; note that a BAA is required for HIPAA-covered exchanges.

Data Handling

Specify transmission method, file formats, validation checks, error handling, and acceptable delivery windows to standardize integration points.

Term & Termination

Define effective date, renewal or review cadence, termination notice, data return or destruction procedures, and post-termination access limitations.

Essential Information Fields to Captures in the Exhibit

PHI Categories: Name, DOB, MRN, encounter data
Recipient Roles: Data holder | data recipient
BAA Required: Yes, if HIPAA-covered entities involved
Retention Period: Specify years and start date
Access Controls: MFA, least privilege
Audit Logging: Timestamps, user IDs, changes

Step-by-Step: Completing a Healthcare Collaborative Exhibit

Follow these steps to prepare and execute the exhibit correctly from drafting through signature and retention.

  • 01
    Draft Terms: Define scope, data fields, and permitted uses in clear language.
  • 02
    Review Compliance: Have privacy, security, and legal teams verify HIPAA and BAA coverage.
  • 03
    Secure Signatures: Obtain authorized signatures with documented consent for electronic execution.
  • 04
    Implement Controls: Coordinate IT to enable encryption, access logging, and scheduled data transfers.

How to Configure an Online Execution Workflow

Set up document routing and authentication that matches the exhibit’s security and audit requirements before inviting signers.

Field Configuration
Identity Proofing Use email+SMS or stronger KBA where higher assurance required
Authentication MFA for internal signers; SMS code or KBA for external partners
Document Format Use PDF/A or DOCX for archival fidelity and searchability
Routing Order Specify sequential or parallel signing based on role and approvals

Where Executed Exhibits Are Stored and Who Receives Them

After execution, distribute final copies to legal, privacy, and operational teams and retain an archival copy per retention rules.

  • Contracting File: Legal keeps signed exhibit attached to master agreement
  • Compliance Folder: Privacy officer stores copies and BAA documentation
  • Operational Teams: IT and data teams receive integration and mapping instructions
  • Audit Archive: Maintain tamper-evident record for audits and investigations

Technical and Integration Considerations for eSignature and Sharing

Choose a platform that supports required authentication, audit trails, and industry integrations to operationalize the exhibit.

  • Formats Supported: PDF, DOCX, XLSX are commonly accepted
  • Integrations: Salesforce, NetSuite, Google Workspace, Box
  • Security Standards: TLS, AES-256, SOC 2 and HIPAA capability

Confirm the platform can retain audit logs, meet any BAA obligations, and export immutable signed copies for legal preservation.

Typical Timelines and Processing Expectations

Set clear internal deadlines for review, signature, and operational onboarding so data exchanges begin without delay.

Draft Review Window:

Allow 10–30 business days for legal and privacy review

Signature Period:

Target execution within 15–30 days after final draft

Implementation Start:

Plan data transfer start 30–60 days after signing

Annual Review:

Schedule compliance review and testing annually

Retention Start:

Retention clocks begin on the effective date

Key Milestones From Draft to Operational Data Exchange

Track these sequential milestones to keep stakeholders aligned and to document compliance checkpoints.

01

Draft Agreement

Prepare exhibit language and list data fields and recipients.

02

Internal Approvals

Legal, privacy, and IT confirm terms and technical feasibility.

03

Execution

Authorized signers sign; execute BAA if required.

04

Operational Launch

Begin data transfers with agreed validation and monitoring.

Common Preparation Mistakes to Avoid

  • Failing to specify exact data fields and formats, which causes integration delays and misinterpretation between systems.
  • Not executing a BAA where required, exposing parties to regulatory risk and potential HIPAA violations.
  • Using vague permitted-use language that allows downstream reuse inconsistent with participant consent or regulatory limits.
  • Overlooking retention and destruction procedures, resulting in noncompliance during audits or breach investigations.

Potential Consequences of an Incomplete or Noncompliant Exhibit

HIPAA Fines: Civil monetary penalties and corrective action requirements
Contract Liability: Damages for breach and indemnity obligations
Data Breach Risk: Reputational loss and notification costs
Regulatory Scrutiny: Increased audit frequency and oversight
Research Delays: IRB holds or data access revocation
Operational Disruption: Integration rollback and remediation expenses

Who Is Typically Authorized to Sign

Chief Medical Officer

Often signs on behalf of a healthcare provider for clinical data-use exhibits; ensures clinical governance and operational alignment with privacy and safety policies.

General Counsel

Signs on behalf of an organization when legal commitments, indemnities, or data-sharing terms carry material risk and require authority to bind the entity.

Real-World Examples of Collaborative Exhibits in Use

These brief examples show how different organizations applied exhibit provisions to operationalize collaborations while managing compliance and integration.

Fertility Centers of Illinois

Needed HIPAA-compliant signatures across multiple sites and specialties

  • Required a single exhibit standardizing permitted uses and retention
  • "The airSlate SignNow team has been exceptional, responsive, the API has been great, and we're extremely happy that we chose airSlate SignNow as a company."

BIS

Prioritized auditability and SOC 2 assurance for partner exchanges

  • Chose precise logging and encryption language in the exhibit
  • "We felt most comfortable with airSlate SignNow given their SOC 2 certification and strict focus on ESIGN and UETA act compliance."

Supporting Documents and File Formats to Include

Attach technical and legal appendices so implementers have everything required to start exchanges without repeated clarification.

Technical Appendix

Provide data field dictionaries, sample files, mapping instructions, and validation rules in CSV or JSON formats.

BAA Attachment

Include a signed business associate agreement when PHI is involved, specifying responsibilities and breach procedures.

Operational Runbook

Add file transfer schedules, escalation paths, and contact points for onboarding and incident response.

Signed Exhibit Copy

Retain a PDF/A copy with embedded audit trail and timestamps for legal preservation.

eSignature Pricing and Feature Comparison Relevant to Executing Exhibits

Compare starting prices and key features that affect volume-based exhibit execution and compliance, including HIPAA capability and envelope limitations.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies Varies Varies Varies
Bulk Send Yes Yes Yes Yes Varies
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Frequently Asked Questions and Troubleshooting

Answers to common questions about preparing, executing, and maintaining a Healthcare Collaborative Exhibit, with practical troubleshooting for typical issues.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.